Cannapharmarx, Inc. SEC filings CPMD
Cannapharmarx, Inc. has 365 filings in SEC EDGAR's recent list, going back to Jun 10, 1999. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 13, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 17, 2026 | Jun 30, 2026 |
| NT 10-Q | Filing | May 18, 2026 | Mar 31, 2026 |
| NT 10-Q | Filing | May 16, 2025 | Mar 31, 2025 |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| NT 10-Q | 10-q extension | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Extension | Mar 27, 2024 | Dec 31, 2023 |
| NT 10-Q | Extension | Nov 14, 2023 | Sep 30, 2023 |
| NT 10-K | Extension | Mar 30, 2023 | Dec 31, 2022 |
| NT 10-Q | Request for extension | Nov 14, 2022 | Sep 30, 2022 |
| NT 10-Q | Extension | Aug 12, 2022 | Jun 30, 2022 |
| EFFECT | Filing | Aug 11, 2022 | — |
| RW | Request for withdrawal | Aug 9, 2022 | — |
| CORRESP | Letter to the SEC | Aug 8, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2022 | — |
| NT 10-Q | Extension | May 16, 2022 | Mar 31, 2022 |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Jun 11, 2021 | — |
| CORRESP | Letter to the SEC | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | May 26, 2021 | — |
| UPLOAD | Letter from the SEC | May 24, 2021 | — |
| EFFECT | Filing | May 4, 2021 | — |
| CORRESP | Letter to the SEC | Apr 28, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2021 | — |
| CORRESP | Letter to the SEC | Apr 21, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2021 | — |
| NT 10-K | 10-k extension | Apr 1, 2021 | Dec 31, 2020 |
| EFFECT | Filing | Jan 25, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Dec 18, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2020 | — |
| DEL AM | Delay request | Dec 2, 2020 | — |
| NT 10-Q | Notice of late filing | Aug 14, 2020 | Jun 30, 2020 |
| NT 10-K | Extension for 10-k | May 14, 2020 | Dec 31, 2019 |
| NT 10-K | Notice of late filing | Apr 1, 2019 | Dec 31, 2018 |
| D | Filing | Mar 13, 2019 | — |
| D/A | Filing | Jan 18, 2019 | — |
| D | Filing | Aug 22, 2018 | — |
| NT 10-K | Filing | Mar 30, 2016 | Dec 31, 2015 |
| D | Filing | Aug 10, 2015 | — |
| D/A | Filing | Aug 7, 2015 | — |
| D/A | Filing | Apr 29, 2015 | — |
| D | Filing | Apr 15, 2015 | — |
| NT 10-Q | Filing | Nov 14, 2014 | Sep 30, 2014 |
| NT 10-Q | Filing | Aug 15, 2014 | Jun 30, 2014 |
| D | Filing | Jun 4, 2014 | — |
| D | Filing | May 21, 2014 | — |
| SC 14F1 | Filing | May 16, 2014 | — |
| NT 10-Q | Filing | May 15, 2014 | Mar 31, 2014 |
| UPLOAD | Letter from the SEC | Feb 3, 2014 | — |
| CORRESP | Letter to the SEC | Jan 30, 2014 | — |
| CORRESP | Letter to the SEC | Jan 30, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2014 | — |
| NT 10-Q | Filing | May 12, 2011 | Mar 31, 2011 |
| NT 10-K | Filing | Mar 24, 2011 | Dec 31, 2010 |
| UPLOAD | Letter from the SEC | Feb 16, 2011 | — |
| CORRESP | Letter to the SEC | Feb 10, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2010 | — |
| NT 10-Q | Filing | Nov 15, 2010 | Sep 30, 2010 |
| UPLOAD | Letter from the SEC | May 4, 2010 | — |
| CORRESP | Letter to the SEC | Apr 14, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2010 | — |
| NT 10-K | Filing | Mar 19, 2010 | Dec 31, 2009 |
| CORRESP | Letter to the SEC | Mar 8, 2010 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2010 | — |
| CORRESP | Letter to the SEC | Jan 19, 2010 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2009 | — |
| 10KSB | Filing | Feb 1, 2008 | Dec 31, 2007 |
| 10QSB | Filing | Nov 15, 2007 | Sep 30, 2007 |
| NT 10-Q | Filing | Nov 14, 2007 | Sep 30, 2007 |
| 10SB12G | Filing | Jul 25, 2007 | — |
| 15-12G | Deregistration | Mar 5, 2001 | — |
| 10QSB | Form 10-qsb | Nov 20, 2000 | Sep 30, 2000 |
| NT 10-Q | Filing | Nov 15, 2000 | Sep 30, 2000 |
| DEFS14A | Filing | Sep 11, 2000 | Oct 6, 2000 |
| PRES14A | Filing | Sep 7, 2000 | Oct 6, 2000 |
| PRES14A | Filing | Aug 25, 2000 | Oct 6, 2000 |
| 10QSB | Form 10qsb | Aug 11, 2000 | Jun 30, 2000 |
| 10QSB | Filing | May 10, 2000 | Mar 31, 2000 |
| SB-2/A | Filing | Mar 16, 2000 | — |
| SB-2 | Filing | Mar 13, 2000 | — |
| 10KSB40 | Filing | Mar 8, 2000 | Dec 31, 1999 |
| DEFS14A | Filing | Feb 8, 2000 | Mar 8, 2000 |
| SB-2/A | Filing | Jan 27, 2000 | — |
| SB-2/A | Filing | Jan 5, 2000 | — |
| SB-2 | Filing | Dec 30, 1999 | — |
| 10QSB | Filing | Dec 13, 1999 | Sep 30, 1999 |
| SB-2/A | Filing | Oct 29, 1999 | — |
| SB-2/A | Filing | Oct 26, 1999 | — |
| SB-2/A | Filing | Sep 17, 1999 | — |
| 8-A12G | Filing | Aug 16, 1999 | — |
| SB-2/A | Filing | Jul 29, 1999 | — |
| SB-2 | Filing | Jun 10, 1999 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View County
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1081938
- Former names
- GOLDEN DRAGON HOLDING CO. (until Oct 27, 2014); CCVG, INC. (until Jan 12, 2011); CONCORD VENTURES, INC. (until Nov 17, 2010); CAVION TECHNOLOGIES INC (until Jul 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.